Biome Australia brings probiotic manufacturing to Australia

Biome Australia has announced a commercial manufacturing agreement with Specialty Probiotics Australia (SPA), an Australian GMP-licensed manufacturer specialising in probiotic production. The company says the partnership will see Biome progressively transition manufacturing of its Activated Probiotics range to Australia, adding a locally made, competitive advantage to its product range as it continues to scale internationally.

“We are excited to be working with Biome and to support them strategically as they scale, by removing barriers in production and the supply chain and by supporting new opportunities in product development,” Specialty Probiotics Australia Chief Executive Officer Craig Silbery said. “Biome and its Activated Probiotics brand are among the most exciting, high-growth brands in the Australian market, and increasingly in global markets, and we look forward to the journey ahead together.”

Producing in Australia in smaller, more frequent batches is expected to reduce inventory holdings, improve stock turn and remove the extended international freight lead times currently associated with each batch. This is expected to reduce capital tied up in inventory and in-transit stock, while also improving the usable shelf life of finished product before it reaches customers.

Onshore manufacturing is also expected to progressively lift Biome’s gross margin from the first commercial batch and requires no capital expenditure from Biome.

The first commercial batch is targeted for September 2026, with the balance of the range targeted to progressively move onshore over approximately the following 18 months, subject to successful commercial scale-up and transition of production.

Image credit: iStock.com/anusorn nakdee